Cargando…
Efficacy of anastrozole in the treatment of hypogonadal, subfertile men with body mass index ≥25 kg/m(2)
BACKGROUND: Anastrozole is a non-steroidal fourth generation aromatase inhibitor that stops the conversion of testosterone to estradiol and has been used as empiric medical therapy for the treatment of male infertility in men with an abnormal testosterone-to-estradiol ratio <10 in order to increa...
Autores principales: | Shah, Tejash, Nyirenda, Themba, Shin, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039603/ https://www.ncbi.nlm.nih.gov/pubmed/33850757 http://dx.doi.org/10.21037/tau-20-919 |
Ejemplares similares
-
The efficacy of anastrozole in subfertile men with and without abnormal testosterone to estradiol ratios
por: Yang, Yang, et al.
Publicado: (2022) -
Obesity and Baseline Estradiol Levels Are Independent Predictors for Initiation of Anastrozole in Hypogonadal Men on Clomiphene Citrate
por: Keihani, Sorena, et al.
Publicado: (2020) -
The effect of duodenojejunal bypass for type 2 diabetes mellitus patients below body mass index 25 kg/m(2): one year follow-up
por: Heo, Yoonseok, et al.
Publicado: (2013) -
What is the failure rate in extending labour analgesia in patients with a body mass index ≥ 40 kg/m(2)compared with patients with a body mass index < 30 kg/m(2)? a retrospective pilot study
por: Eley, Victoria A., et al.
Publicado: (2015) -
A body mass index over 22 kg/m(2) at college age is a risk factor for future diabetes in Japanese men
por: Someya, Yuki, et al.
Publicado: (2019)